Tests glue reinforcement of pancreas-to-intestine join after pancreatic surgery
Tests whether glue reinforcement reduces pancreatic fistula in adults after pancreatic surgery.
Plain-language title generated from the registry record
Registry title: Reinforced Pancreaticojejunostomy With or Without glubran2
Key facts
- Where
- Minya, EgyptSee the site
- Phase
- Phase 2
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Source: NCT06756074, who can take part
Where in Egypt
- Liver and GIT hospital , Minia UniversityMinya, EgyptTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Minia University
- Trial code
- NCT06756074
- Record updated
- 16 March 2026
- Original description
Pancreatic fistula is one of the most serious complication after pancreatoduodenectomy. To reduce pancreatic fistula, many authors recommend different techniques in pancreatojejunostomy. The purpose of this study is to determine which is the best method in preventing pancreatic fistula by enforce pancreaticojejunostomy with tissue glue .Read full original descriptionShow less
Impact of Reinforced Pancreaticojejunostomy With or Without Tissue Adhesive Glue Modified Cyanoacrylate (Glubran 2) Following Pancreaticoduodenectomy, Randomized Controlled Clinical Trial.
Pancreatic fistula is one of the most serious complication after pancreatoduodenectomy. To reduce pancreatic fistula, many authors recommend different techniques in pancreatojejunostomy. The purpose of this study is to determine which is the best method in preventing pancreatic fistula by enforce pancreaticojejunostomy with tissue glue .
Inclusion: All the patients undergoing pancreaticoduodenectomy for cancer; Patients able to give their informed consent.
Exclusion: Unfit patients for surgery due to severe medical illness; Inoperable patients by imaging studies, irresectable tumors after laparotomy or diagnostic laparoscopy; Presence of distant metastasis ; Patients refused to participate in the study.